Literature DB >> 29388492

Leptin and chronic kidney diseases.

Song Mao1, Li Fang1, Fen Liu1, Siqiong Jiang1, Liangxia Wu1, Jianhua Zhang2.   

Abstract

Chronic kidney diseases (CKD), a common outcome of various kidney diseases, cause a series of refractory complications, which lead to great economic burdens on patients. The clinical outcomes of CKD depend on various factors, including metabolic disorders. Leptin, a peptide hormone, produced in adipose tissues, plays an important role in regulating food consumption and energy expenditure. Leptin also influences the immune system and hematopoiesis. Increased leptin status is observed in CKD, leptin deficiency attenuates the immune response in nephritis. Conversely, leptin inhibits the development of obesity, which is closely associated glomerular disorder. Now, the precise role of leptin in CKD remains elusive. This review will give an integrated understanding of the potential role of leptin and its interactions with other signal molecules in CKD.

Entities:  

Keywords:  Chronic kidney diseases; leptin; prognosis

Mesh:

Substances:

Year:  2018        PMID: 29388492     DOI: 10.1080/10799893.2018.1431278

Source DB:  PubMed          Journal:  J Recept Signal Transduct Res        ISSN: 1079-9893            Impact factor:   2.092


  6 in total

Review 1.  Metabolic Syndrome-Related Kidney Injury: A Review and Update.

Authors:  Lirong Lin; Wei Tan; Xianfeng Pan; En Tian; Zhifeng Wu; Jurong Yang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-23       Impact factor: 6.055

Review 2.  Impact of adipose tissue in chronic kidney disease development (Review).

Authors:  Daniela Miricescu; Daniela Gabriela Balan; Adrian Tulin; Ovidiu Stiru; Ileana Adela Vacaroiu; Doina Andrada Mihai; Cristian Constantin Popa; Mihaly Enyedi; Andrei Sorin Nedelea; Adriana Elena Nica; Constantin Stefani
Journal:  Exp Ther Med       Date:  2021-03-23       Impact factor: 2.447

Review 3.  Mitochondrial Dysfunction and Acute Fatty Liver of Pregnancy.

Authors:  Raghu Ramanathan; Jamal A Ibdah
Journal:  Int J Mol Sci       Date:  2022-03-25       Impact factor: 6.208

4.  Adiponectin and Leptin as Biomarkers of Disease Activity and Metabolic Disorders in Rheumatoid Arthritis Patients.

Authors:  Bożena Targońska-Stępniak; Krzysztof Grzechnik
Journal:  J Inflamm Res       Date:  2022-10-13

5.  Role of mitochondrial quality control in the pathogenesis of nonalcoholic fatty liver disease.

Authors:  Ruibing Li; Sam Toan; Hao Zhou
Journal:  Aging (Albany NY)       Date:  2020-03-26       Impact factor: 5.682

6.  Increased Expression of the Leptin Gene in Adipose Tissue of Patients with Chronic Kidney Disease-The Possible Role of an Abnormal Serum Fatty Acid Profile.

Authors:  Justyna Korczyńska; Aleksandra Czumaj; Michał Chmielewski; Maciej Śledziński; Adriana Mika; Tomasz Śledziński
Journal:  Metabolites       Date:  2020-03-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.